Sun Pharma

Sun Pharma to Acquire Checkpoint Therapeutics

Indian generic drug maker Sun Pharma agreed to acquire US immunotherapy and targeted oncology company Checkpoint Therapeutics for an upfront value of $355 million. The transaction is expected to be completed in the second quarter of 2025 and is subject to customary closing conditions.

News

India's Sun Pharma, US Merck in Generics Joint Venture

Top-Feature

Brenntag SE

Brenntag Downsizes Management Board, Retains Both Divisions

CHEManager International c/o Wiley-VCH GmbH

API Manufacturing

CHEManager International c/o Wiley-VCH GmbH

20 Years of CHEManager International

Nova-Institut GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Dow Chemical Company

Anchored in Sustainability

Easyfairs Deutschland GmbH

Leading the way. Driving results.

Sasol

Leading Transformation

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Together for Sustanability (TFS)

Driving Sustainability Through Collaboration

Virtual Event

Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.